ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Extramural Advisory Board Members Listed

October 20, 1995

In Brief: Mammography Quality assurance Act Introduced Laurence Marton Succeeds Brown At Wisconsin

November 1, 1991

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005

Complete List of Recommendations by Centers Committee

October 18, 1996

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996